Please visit our COVID-19 Resources page for more information on stroke care during the coronavirus pandemic. 

News Story

UTHealth Houston Stroke Institute study on Alzheimer’s disease uses nationwide electronic health records to conduct an analysis of risk factors in Alzheimer’s disease and related dementias

UTHealth Houston Institute for Stroke and Cerebrovascular Disease Researchers Publish Study On Counterfactual Analysis of Differential Comorbidity Risk Factors in Alzheimer’s Disease and Related Dementias

Alzheimer’s disease (AD) is the sixth leading cause of death in the United States, affecting 6 million Americans aged 65 and older. Dr. Yejin Kim and her team discovered different comorbidities that predispose older African Americans to AD compared to Caucasian counterparts. 

Quick Links for this News Story:

Read the Full Article 

Listen to the Podcast episode 

In this episode, Dr. Seema Aggarwal sat down with Dr. Yejin Kim to discuss Dr. Kim, along with UTHealth Houston and Stroke Institute researcher’s, article from March 2022, a counterfactual analysis of differential comorbidity risk factors in Alzheimer’s disease and related dementias. Their analysis discovered different comorbidities that predispose older African Americans to AD compared to Caucasian counterparts. The findings from their study, which used data collected from nationwide electronic health records will assist in understanding risk of comorbid disease to AD

Learn more about the authors of article

site var = uth